In the group of primary ovarian carcinomas, 39 out of 77 cases (50.6%) were PLK3 positive (Table 1, Figure 1), usually with pronounced PLK3 expression along the infiltrative tumour margins. The gene discussed is PLK3; the disease is ovarian carcinoma.